July 14, 2015
PHILADELPHIA AND PLYMOUTH MEETING, Pa. - July 15, 2015 - Temple University Health System (TUHS) announced today that it has selected Accolade, the market-leading consumer health engagement platform for large employers, health systems and payers, to provide personal health assistance services to its employees and dependents.
As of July 1, 2015, every family covered through TUHS now has its own personal Accolade Health Assistant® to help them navigate the healthcare system, resolve benefits and claims issues, find the right provider, take advantage of TUHS benefits and resources, understand their treatment options and coordinate care across their entire healthcare journey.
“Our employees help to bring the world's most advanced medical care and technologies to the patients we're privileged to serve,” said Larry R. Kaiser, MD, FACS, President and CEO of Temple University Health System. “When they become the patient, they too can benefit from expert guidance navigating the healthcare resources that are available to them. As a member of Accolade's Medical Advisory Board, I've been fortunate to observe first-hand the outstanding work that Accolade does, and I'm pleased to bring these benefits to our own colleagues and families.”
Accolade Health Assistants®— supported by technology and a full team of clinicians and specialists — take the time to build trusted relationships with the employees and family members they serve, creating highly individualized care plans that factor in not only health status but also the person's unique life context, knowledge and emotions. Through this high-touch, high-tech approach, Accolade is able to engage 10 times more people than conventional health management programs while delivering superior healthcare savings (5-15% reduction in the total cost of care annually) and consumer satisfaction (98% satisfaction and world-class Net Promoter Score of 70+).
“What's most exciting about this new relationship with TUHS is that a leading academic medical center and innovator recognizes the value that Accolade provides within the healthcare system,” said Tom Spann, chief executive officer of Accolade. “We're truly honored and look forward to creating a great experience for the thousands of individuals we'll be serving in the program.”
Since it began operations in 2009, Accolade has steadily grown, now serving more than half a million Americans and employing more than 600 people in Plymouth Meeting, PA, and Scottsdale, AZ.
Accolade is the country's leading consumer healthcare engagement and influence platform for large self-insured employers, health systems and payer organizations. We help consumers navigate the complex world of healthcare and benefits, find the right providers and get the right care the first time. Our fully integrated solution is delivered through a powerful combination of Accolade Health Assistants® and advanced technology. By addressing some of the biggest problems facing healthcare - low engagement, lack of trust, and consumer knowledge gaps and errors - we're able to consistently save our customers 5-15 percent per year while delighting the individuals and family members we serve. Headquartered in Plymouth Meeting, Pa. Accolade has been recognized as a Top Workplace in Philadelphia for five consecutive years. For more information, visit www.accolade.com.
About Temple University Health System Temple University Health System (TUHS) is a $1.8 billion academic health system dedicated to providing access to quality patient care and supporting excellence in medical education and research. The Health System consists of Temple University Hospital (TUH), ranked among the “Best Hospitals” in the region by U.S. News & World Report; TUH-Episcopal Campus; TUH-Northeastern Campus; Fox Chase Cancer Center, an NCI-designated comprehensive cancer center; Jeanes Hospital; Temple Transport Team, a ground and air-ambulance company; and Temple Physicians, Inc., a network of community-based specialty and primary-care physician practices. TUHS is affiliated with Temple University School of Medicine.